Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02345356 · ClinicalTrials.gov registry record
A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
A clinical trial of Atrial Fibrillation and Pulmonary Embolism, sponsored by University of Puerto Ri.
- Completed
- Registry status
- 200
- Enrollment target
- 3
- Study locations
NCT02345356 is a study of Atrial Fibrillation and Pulmonary Embolism that has completed, run by University of Puerto Ri. The registered enrollment target is 200 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT02345356, a study of Atrial Fibrillation and Pulmonary Embolism, has completed, sponsored by University of Puerto Ri.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 3
- Study locations
Study Summary
Caribbean Hispanics are a population with a disproportionately high prevalence of cardio-metabolic disorders but with a limited expectation of benefits from current pharmacogenetic algorithms derived mainly in subjects of relatively pure ancestry. The investigators focus on warfarin responses to develop urgently-needed DNA-driven prescription guidelines for this population, who have arisen from European, West African and Amerindian genomic origins to produce a highly heterogeneous population. Our project combines admixture analysis and DNA-sequencing with development of more accurate rules for better predictability of warfarin dosing to immediately serve this medically underserved population.
Conditions Studied
Interventions
- GENETIC Genotype-guided
- OTHER Standard-of-Care
Study Locations (3)
Other
- UPR University Hospital at Carolina - Carolina
- UDH University Hospital at Centro Medico - San Juan
Florida
- Miami VA Healthcare System - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-01 |
| Est. Completion | 2022-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02345356
The ClinicalTrials.gov registry entry for NCT02345356 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (93% lower). The listed sponsor is University of Puerto Ri, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Genotype-guided is the first listed.
NCT02345356 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Florida.
Frequently Asked Questions
What is clinical trial NCT02345356 about?
NCT02345356 is a clinical study titled "A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics". Caribbean Hispanics are a population with a disproportionately high prevalence of cardio-metabolic disorders but with a limited expectation of benefits from current pharmacogenetic algorithms derived mainly in subjects of relatively pure ancestry. The investigators focus on warfarin responses to dev...
What is the current status of trial NCT02345356?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2016-01. Estimated completion is 2022-05-17.
What conditions does trial NCT02345356 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Pulmonary Embolism, Deep Vein Thrombosis, Cardiac Valvular Insufficiency, Coagulopathies.
What interventions are being tested in trial NCT02345356?
The interventions under investigation include: Genotype-guided (GENETIC), Standard-of-Care (OTHER).
Who is sponsoring clinical trial NCT02345356?
This trial is sponsored by University of Puerto Ri, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02345356 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.